Dailypharm Live Search Close

South Korea recovered Sartan products with AZBT impurities

By Lee, Tak-Sun | translator Choi HeeYoung

21.08.09 12:08:32

°¡³ª´Ù¶ó 0
Recalls are also being carried out in Europe, including the U.K. and Spain, and test results are imminent



The recovery of Sartan medicines containing 'AZBT' has also begun in Korea. Three products containing Irbesartan, manufactured in 2021, were voluntarily recovered by related pharmaceutical companies. Starting in Canada in May, recovery of Sartan containing AZBT is spreading around the world to Europe and Asia.

The MFDS announced on the 6th that it would voluntarily collect three Irbesartan-containing items (Rovelito, CoAprovel, and Aprovel) manufactured before 2021.

Sanofi, which supplies Irbesartan in Korea, pre-emptively delivered to distributors and vendors that it would voluntarily recover Irbesartan products produced before January 2021.

Sanofi explained why the impuri

Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)